GRD Biotechnology Acquisition Files for $40M IPO

GRD Acquisition today registered to offer 4 million shares at $10 each.

The SPAC intends to focus on the Asian biotechnology sector.

No underwriter was listed in the S-1 registration statement.

Chairman and CEO Zhonghua Gao has more than 20 years of experience in biotechnology, human cell and gene biological testing, and general health, according to the S-1. He has served as Dean of the Gene Technology Research Institute, Chairman of Zhongjianlian Biotechnology Co., Ltd., and Chairman of Sichuan Gaorunde Biotechnology Co., Ltd. 

GRD said it would apply for a NASDAQ listing under the symbol CGRD. Read more.

Source: GRD Biotechnology Acquisition Files for M IPO